Prescription Pattern of Antihypertensive Agents in T2DM Patients Visiting Tertiary Care Centre in North India

Table 4

Multiple logistical regression showing variables associated with prescribing of antihypertensive drugs.

Variables	ACEI		ARBs		BBs		CCBs		Diuretics
	OR (95%CI)	𝑃 value	OR (95%CI)	𝑃 value	OR (95%CI)	𝑃 value	OR (95%CI)	𝑃 value	OR (95%CI)	𝑃 value
Age (≤55 versus >55 years)	1.00 (0.99–1.01)	0.986	1.21 (0.95–1.55)	0.12	0.99 (0.97–1.01)	0.394	1 (0.99–1.018)	0.482	1.17 (1.03–1.35)	0.019
Sex (male versus female)	1.23 (0.96–1.57)	0.095	0.83 (0.65–1.06)	0.15	0.95 (0.66–1.36)	0.77	0.8 (0.61–1.05)	0.11	0.89 (0.68–1.18)	0.436
DDM (≤9 versus >9 years)	0.99 (0.77–1.28)	0.973	1.24 (0.96–1.59)	0.09	0.93 (0.81–1.06)	0.267	1.08 (0.82–1.43)	0.574	0.97 (0.72–1.28)	0.81
DHTN (≤5 versus >5 yrs)	1.07 (0.69–1.11)	0.57	1.61 (1.24–2.08)	<0.001	1.26 (0.87–1.83)	0.219	1.27 (1.05–1.51)	0.04	2.05 (1.55–2.74)	<0.001
BMI* (≤5 versus >5 yrs)	1.14 (0.89–1.46)	0.3	1.03 (0.81–1.32)	0.806	1.00 (0.988–1.02)	0.647	1.29 (0.97–1.71)	0.073	1.42 (0.64–1.12)	0.017
Waist*	0.92 (0.69–1.23)	0.568	1.23 (0.93–1.65)	0.14	0.99 (0.67–1.48)	0.99	1.23 (0.87–1.37)	0.242	1.16 (0.81–1.67)	0.41
SBP (≤130 versus >130 mmHg)	0.60 (0.46–0.79)	<0.001	1.09 (0.84–1.42)	0.493	1 (0.99–1.02)	0.274	1.47 (1.08–2)	0.014	1.47 (1.07–2.02)	<0.001
DBP (≤80 versus >80 mmHg)	0.81 (0.63–1.04)	0.102	1.19 (0.93–1.53)	0.166	0.98 (0.97–1.00)	0.146	1.5 (1.14–2.01)	0.005	1.2 (0.87–1.57)	0.29
FPG (≤110 versus >110 mg/dL)	1.07 (0.81–1.41)	0.642	0.94 (0.71–1.24)	0.659	1.03 (0.68–1.55)	0.889	0.86 (0.64–1.2)	0.368	1.21 (0.88–1.68)	0.241
PPG (≤140 versus >140 mg/dL)	1.18 (0.85–1.63)	0.322	1.01 (0.73–1.4)	0.948	1.14 (0.7–1.84)	0.607	0.92 (0.65–1.3)	0.646	0.89 (0.62–1.28)	0.53
Neuro (no versus yes)	0.78 (0.59–1.04)	0.093	1.24 (0.94–1.63)	0.132	1.17 (0.77–1.77)	0.463	1.56 (1.13–2.18)	0.008	1.35 (0.97–1.87)	0.07
Nephro (no versus yes)	0.98 (0.76–1.26)	0.878	1.43 (1.12–1.83)	0.004	—	—	1.08 (0.82–1.43)	0.57	1.42 (1.08–1.88)	0.014
Retino (no versus yes)	1.04 (0.87–1.24)	0.662	1.24 (1.04–1.47)	0.017	—	—	1.39 (1.15–1.68)	<0.001	1.19 (0.98–1.4)	0.069
CAD (no versus yes)	1.12 (0.79–1.59)	0.507	0.84 (0.59–1.12)	0.324	2.52 (1.44–4.41)	<0.001	—	—	1.89 (1.32–2.73)	<0.001
CVA (no versus yes)	1.55 (0.76–3.19)	0.23	0.55 (0.27–1.13)	0.106	1.46 (0.59–3.6)	0.407	1.53 (0.75–3.16)	0.246	1.46 (0.69–3.05)	0.316
DF (no versus yes)rs)	0.81 (0.65–1.009)	0.061	1.18 (0.95–1.47)	0.14	1.15 (0.89–1.49)	0.279	0.83 (0.63–1.09)	0.194	1.21 (0.97–1.49)	0.088
HbA1C (≤7 versus >7%.)	1.006 (0.99–1.02)	0.334	0.99 (0.98–1)	0.548	—	—	0.98 (0.93–1.03)	0.409	0.99 (0.98–1.01)	0.633
Scr (≤1.2 versus >1.2%)	0.84 (0.71–0.99)	0.039	1.09 (0.94–1.28)	0.24	0.97 (0.77–1.22)	0.816	1.2 (1.04–1.42)	0.016	1.52 (1.25–1.85)	<0.001